KIR3DL2 | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

21 March 2024

Innate gets a new lacutamab blow

Green traffic light

Regulatory

4 January 2024

Lacutamab lift boosts Innate

Conferences Trial results

10 December 2023

ASH 2023 – lacutamab’s late-line promise on hold

Subscribe to KIR3DL2